Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease
Qi-wen Han, Yu‐He Yuan, Nai‐Hong Chen
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 96, pp. 109745-109745
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Cannabis: a multifaceted plant with endless potentials
Eric Fordjour, Charles F. Manful, Albert Adu Sey, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 46
Neuroprotective and Immunomodulatory Action of the Endocannabinoid System under Neuroinflammation
L.A. Kasatkina, Sonja Rittchen, Eva M. Sturm
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5431-5431
Open Access | Times Cited: 85
Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson’s Disease
Claudio Giuliano, Francavilla Miriam, Gerardo Ongari, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8920-8920
Open Access | Times Cited: 52
Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty
Alexandru Vasincu, Răzvan-Nicolae Rusu, Daniela Carmen Ababei, et al.
Biology (2022) Vol. 11, Iss. 3, pp. 440-440
Open Access | Times Cited: 24
Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery
Siyuan Shen, Chao Wu, Zhiqian Yang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies
Vamsi Reddy, Dayton Grogan, Meenakshi Ahluwalia, et al.
The EPMA Journal (2020) Vol. 11, Iss. 2, pp. 217-250
Open Access | Times Cited: 34
Can Physical Activity Support the Endocannabinoid System in the Preventive and Therapeutic Approach to Neurological Disorders?
Tomasz Charytoniuk, Hubert Żywno, Karolina Konstantynowicz-Nowicka, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4221-4221
Open Access | Times Cited: 28
The Neuroprotective Effects of the CB2 Agonist GW842166x in the 6-OHDA Mouse Model of Parkinson’s Disease
Hao Yu, Xiaojie Liu, Bixuan Chen, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3548-3548
Open Access | Times Cited: 25
Phytocannabinoids: General Aspects and Pharmacological Potential in Neurodegenerative Diseases
Graziella dos Reis Rosa Franco, Scott D. Smid, Cláudio Viegas
Current Neuropharmacology (2020) Vol. 19, Iss. 4, pp. 449-464
Open Access | Times Cited: 27
Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
Barbara Vuić, Tina Milos, Lucija Tudor, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3000-3000
Open Access | Times Cited: 12
Therapeutic Implications of Renin–Angiotensin System Modulators in Alzheimer’s Dementia
Daniela Carmen Ababei, Veronica Bild, Ioana Macadan, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2290-2290
Open Access | Times Cited: 6
Cannabis Phytochemicals: A Review of Phytocannabinoid Chemistry and Bioactivity as Neuroprotective Agents
Dylan T. Marsh, Scott D. Smid
Australian Journal of Chemistry (2020) Vol. 74, Iss. 6, pp. 388-404
Closed Access | Times Cited: 16
Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline?
Jenny L. Wilkerson, Joshua A. Bilbrey, Jasmine S. Felix, et al.
Pharmacology Biochemistry and Behavior (2021) Vol. 206, pp. 173192-173192
Closed Access | Times Cited: 14
The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases
Ivona Maria Tudorancea, Mitică Ciorpac, Gabriela Dumitrița Stanciu, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2492-2492
Open Access | Times Cited: 8
Zebrafish as an Animal Model in Cannabinoid Research
Joanna Izabela Lachowicz, Aleksandra Szopa, Katarzyna Ignatiuk, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10455-10455
Open Access | Times Cited: 4
Outcomes and Outlooks of Therapeutic Application of Modulators of Endogenous Cannabinoid System in Parkinson's Disease
Л. Г. Хаспеков, С. Н. Иллариошкин
(2024)
Open Access | Times Cited: 1
Therapeutic Application of Modulators of Endogenous Cannabinoid System in Parkinson’s Disease
Л. Г. Хаспеков, С. Н. Иллариошкин
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8520-8520
Open Access | Times Cited: 1
Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons
Rafael Rivas‐Santisteban, Ana Muñoz, Jaume Lillo, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
The Role of Cannabinoid Type 2 Receptors in Parkinson’s Disease
Maria Sofia Basile, Emanuela Mazzon
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2986-2986
Open Access | Times Cited: 7
Exercise Improves Orofacial Pain and Modifies Neuropeptide Expression in a Rat Model of Parkinson’s Disease
Karina Henrique Binda, Marucia Chacur, Daniel Oliveira Martins
Neurotoxicity Research (2023) Vol. 41, Iss. 5, pp. 459-470
Closed Access | Times Cited: 3
Curcumin, Resveratrol and Cannabidiol as Natural Key Prototypes in Drug Design for Neuroprotective Agents
Flávia P. Dias Viegas, Vanessa Silva Gontijo, Matheus de Freitas Silva, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 7, pp. 1297-1328
Open Access | Times Cited: 7
Possible role of endocannabinoids in olfactory and taste dysfunctions in Alzheimer’s and Parkinson’s patients and volumetric changes in the brain
Emine Petekkaya, Berna Kuş, Serdar Doğan, et al.
Journal of Clinical Neuroscience (2022) Vol. 100, pp. 52-58
Closed Access | Times Cited: 5
Therapeutic Molecular Insights into the Active Engagement of Cannabinoids in the Therapy of Parkinson’s Disease: A Novel and Futuristic Approach
Vaibhav Jain, Tapan Behl, Aayush Sehgal, et al.
Neurotoxicity Research (2022) Vol. 41, Iss. 1, pp. 85-102
Closed Access | Times Cited: 5
Machine learning study: from the toxicity studies to tetrahydrocannabinol effects on Parkinson's disease
Mehmet Ali Yucel, İbrahim Özçelik, Öztekin Algül
Future Medicinal Chemistry (2023) Vol. 15, Iss. 4, pp. 365-377
Closed Access | Times Cited: 2
CBD’s potential impact on Parkinson’s disease: An updated overview
El Ghachi Hafida, Soulimani Rachid, Halima Gamrani, et al.
Open Medicine (2024) Vol. 19, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top